Mel Wickremasinghe

277 posts

Mel Wickremasinghe

Mel Wickremasinghe

@mwickremas

Respiratoryphysician interested in digital healthcare care, ethical AI for health ,lung fibrosis, orchestral music , energy therapy

United Kingdom Katılım Aralık 2013
241 Takip Edilen226 Takipçiler
Mel Wickremasinghe
Mel Wickremasinghe@mwickremas·
The Medico Orchestra at Imperial (ICHNT) is reborn this week, the incredible Clara Wernig soloist, Matthew Taylor conductor
English
0
0
2
113
Mel Wickremasinghe retweetledi
patientMpower
patientMpower@patientMpower·
We are delighted to welcome new members to our panel of clinical advisers. Welcome to Dr Ayodeji Adegunsoye, Dr Melissa Lesko, Prof. Jeff Swigris and Dr Melissa Wickremasinghe. Looking forward to great discussions! rb.gy/0j0bw @SwigOutFishing @drdayjee @mwickremas
patientMpower tweet media
English
2
2
4
498
Mel Wickremasinghe
Mel Wickremasinghe@mwickremas·
@ReemKelani amazing concert beautiful singing and piano ! Thank you so much for such a wonderful evening
English
1
0
1
0
Mel Wickremasinghe retweetledi
patientMpower
patientMpower@patientMpower·
Our poster on feasibility of home spirometry in ILD is in Hall 7 right now. The study led by Dr @mwickremas, had high patient adherence & acceptability with home spirometry & oximetry on 91% of study days #ERSCongress #ERS2022
patientMpower tweet media
English
1
4
26
0
Mel Wickremasinghe retweetledi
patientMpower
patientMpower@patientMpower·
Given sensitivity of frequent spirometry in predicting progression of ILDs home spirometry is a realistic and highly valuable alternative to clinic assessment @mwickremas #ERS2022 #ERSCongress2022
English
0
2
3
0
Mel Wickremasinghe retweetledi
Qureight
Qureight@qureight·
Today we announce our IPF Scientific Advisory Board with leading global experts to help us implement our platform technology with a growing number of biopharma partners worldwide @TobyMMaher @drphilmol Paul Ford, Bill Bradford and Mel Wickremasinghe. qureight.com/news/qureight-…
Qureight tweet media
English
0
4
13
0
Mel Wickremasinghe retweetledi
patientMpower
patientMpower@patientMpower·
<2 weeks until ERS 2022 - so much to look forward to: New pMp data from the #ILD study with lead @mwickremas Poster from @wlinng at partner site @Beaumont_Dublin on remote early detection of CT-ILD progression Plus new #ILD collaborations See you at stand J.03A in Barcelona!
patientMpower tweet media
English
1
2
4
0
Mel Wickremasinghe retweetledi
patientMpower
patientMpower@patientMpower·
Exciting news! Ethics committee review of our planned clinical trial assessing health economics of remote monitoring in ILD with PI @mwickremas has commenced. Fingers crossed for good news! Full update here . #IPF hubs.la/Q019tpSh0
English
0
2
5
0
Mel Wickremasinghe retweetledi
Mel Wickremasinghe retweetledi
Steve Jones
Steve Jones@ActionPFsteve·
50% OF UK IPF PATIENTS ARE DENIED ACCESS TO ANTIFIBROTIC TREATMENT BY NICE RULES. Early stage IPF patients (FVC > 80%) and those with advanced symptoms (FVC>50%) cannot be prescribed. This is grossly unfair and results in worse outcomes and ultimately shorter lives
English
4
18
59
0
Luke O'Shea
Luke O'Shea@LukeOShea1·
Excited to see our patient app now can let patients enter data, such as Blood Pressure, also viewable by @uclh clinicians. I think this is a UK first for patients to be able to enter data into their main electronic health record, but let me know if I’m wrong. 😀
Luke O'Shea tweet mediaLuke O'Shea tweet media
English
19
18
143
0
Mel Wickremasinghe retweetledi
Steve Jones
Steve Jones@ActionPFsteve·
There are 70,000 people living with ILD in the UK. It is unclear whether government guidance on extreme vulnerability and shielding covers ILD patients. As yet, very few patients have been contacted by either the NHS or their GP.
English
3
9
15
0